Research Article
Additional Postoperative Radiotherapy Prolonged the Survival of Patients with I-IIA Small Cell Lung Cancer: Analysis of the SEER Database
Figure 2
Survival curves for stage I-IIA SCLC patients with/without PORT before and after PSM. (a, b) Before PSM, additional PORT demonstrated no significance on OS (a) and CSS (b) for stage I-IIA SCLC patients compared with bimodality (surgery plus adjuvant chemotherapy, median OS: 7.58 vs. 5.08 years, HR = 0.84 [0.59, 1.22], ; median CSS: 11.33 vs. 9.33 years, HR = 0.73 [0.47, 1.11], ). (c, d) After PSM, additional PORT prolonged the OS (c) and CSS (d) for stage I-IIA SCLC patients (median OS: 8.58 vs. 5.17, HR = 0.61 [0.39, 0.96], ; median CSS: 11.33 vs. 8.08, HR = 0.47 [0.27–0.82], ). PSM: propensity score matching; PORT: postoperative radiotherapy.
(a) |
(b) |
(c) |
(d) |